DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+33.56%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$5.42B
AUM Growth
+$5.42B
(+19%)
Cap. Flow
+$277M
Cap. Flow
% of AUM
5.11%
Top 10 Holdings %
Top 10 Hldgs %
57.84%
Holding
242
New
154
Increased
21
Reduced
12
Closed
14
Top Buys
| 1 |
Oscar Health
OSCR
|
$103M |
| 2 |
Baxter International
BAX
|
$52.5M |
| 3 |
Revolution Medicines
RVMD
|
$38.4M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
$36.7M |
| 5 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
$34.4M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$41.2M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$38.5M |
| 3 |
Merus
MRUS
|
$23.6M |
| 4 |
Owens & Minor
OMI
|
$23.2M |
| 5 |
Roivant Sciences
ROIV
|
$18.7M |
Sector Composition
| 1 | Healthcare | 78.16% |
| 2 | Technology | 0.1% |
| 3 | Industrials | 0.09% |
| 4 | Consumer Discretionary | 0.08% |
| 5 | Consumer Staples | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
The Oncology Institute
TOI
$318M
| $6.85M | 0.13% |
3,360,052
| – | – |
|
52
Cogent Biosciences
COGT
$1.69B
| $6.41M | 0.12% |
1,089,345
| – | – |
|
|
VIGL
53
DELISTED
Vigil Neuroscience
VIGL
| $3.97M | 0.07% |
1,173,523
-653,877
| -36% | -$2.21M |
|
54
Annexon
ANNX
$226M
| $2.65M | 0.05% |
583,913
| – | – |
|
|
OMIC
55
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $2.29M | 0.04% |
4,984,871
| – | – |
|
56
GeneDx Holdings
WGS
$3.72B
| $1.77M | 0.03% |
643,110
-610,785
| -49% | -$1.68M |
|
|
NYXH
57
Nyxoah
NYXH
$234M
| $811K | 0.02% |
174,842
-225,414
| -56% | -$1.05M |
|
58
Ramaco Resources Class A
METC
$1.71B
| $722K | 0.01% |
+42,021
| New | +$722K |
|
59
Mine Safety
MSA
$6.68B
| $673K | 0.01% |
+3,987
| New | +$673K |
|
60
Altria Group
MO
$113B
| $577K | 0.01% |
+14,296
| New | +$577K |
|
61
NVIDIA
NVDA
$4.24T
| $568K | 0.01% |
+1,146
| New | +$568K |
|
62
TriMas Corp
TRS
$1.57B
| $555K | 0.01% |
+21,896
| New | +$555K |
|
63
Pilgrim's Pride
PPC
$10.6B
| $552K | 0.01% |
+19,960
| New | +$552K |
|
|
AFIB
64
DELISTED
Acutus Medical, Inc. Common Stock
AFIB
| $537K | 0.01% |
2,660,808
| – | – |
|
65
Johnson & Johnson
JNJ
$427B
| $510K | 0.01% |
+3,254
| New | +$510K |
|
66
Murphy Oil
MUR
$3.55B
| $496K | 0.01% |
+11,625
| New | +$496K |
|
67
Woodward
WWD
$14.8B
| $491K | 0.01% |
+3,610
| New | +$491K |
|
68
Andersons Inc
ANDE
$1.4B
| $490K | 0.01% |
+8,517
| New | +$490K |
|
69
Visteon
VC
$3.38B
| $475K | 0.01% |
+3,803
| New | +$475K |
|
70
KKR & Co
KKR
$124B
| $465K | 0.01% |
+5,610
| New | +$465K |
|
71
Leidos
LDOS
$23.2B
| $453K | 0.01% |
+4,182
| New | +$453K |
|
72
Mesa Laboratories
MLAB
$373M
| $452K | 0.01% |
+4,313
| New | +$452K |
|
73
DexCom
DXCM
$29.5B
| $452K | 0.01% |
+3,640
| New | +$452K |
|
74
Maximus
MMS
$4.95B
| $443K | 0.01% |
+5,277
| New | +$443K |
|
|
JNPR
75
DELISTED
Juniper Networks
JNPR
| $429K | 0.01% |
+14,540
| New | +$429K |
|